|
HS Code |
146258 |
| Active Ingredient | Isosorbide Dinitrate |
| Strength | variable (in mixture) |
| Excipient Content | Lactose, Starch or Phosphoric Acid ≥60% |
| Dosage Form | mixture (composition containing excipients) |
| Route Of Administration | oral |
| Pharmacologic Class | nitrate vasodilator |
| Primary Use | anti-anginal |
| Mechanism Of Action | releases nitric oxide, causing vasodilation |
| Color | varies (dependant on excipient) |
| Storage Conditions | store at room temperature, protect from moisture |
| Prescription Status | prescription-only |
| Manufacturer Variability | multiple manufacturers |
| Fda Approval | approved for angina pectoris |
| Side Effects | may include headache, dizziness, hypotension |
| Contraindications | hypersensitivity to nitrates |
As an accredited Isosorbide Dinitrate Mixture [Lactose, Starch Or Phosphoric Acid ≥60%] factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a 100g white, sealed plastic bottle labeled "Isosorbide Dinitrate Mixture, ≥60% (with Lactose, Starch or Phosphoric Acid)." |
| Shipping | Isosorbide Dinitrate Mixture (with Lactose, Starch, or Phosphoric Acid ≥60%) should be shipped in tightly sealed containers, protected from moisture and extreme temperatures. It must comply with local regulations for pharmaceuticals, be labeled as non-hazardous due to the high dilution, and handled carefully to avoid contamination or degradation during transit. |
| Storage | Store Isosorbide Dinitrate Mixture [Lactose, Starch, or Phosphoric Acid ≥60%] in a tightly closed container at room temperature (15–30°C), protected from moisture, heat, and direct sunlight. Keep away from incompatible substances and ignition sources. Ensure the storage area is well-ventilated, dry, and secure, and restrict access to authorized personnel only. Follow all relevant safety regulations and guidelines. |
Applications of Isosorbide Dinitrate Mixture [Lactose, Starch Or Phosphoric Acid ≥60%] in Industrial ManufacturingIsosorbide dinitrate mixtures containing lactose, starch, or phosphoric acid find specialized use across several regulated industrial sectors. Our material, manufactured under strict quality controls, supports downstream producers in both pharmaceutical and technical applications with defined regulatory requirements and functional roles in their process chains. 1. Pharmaceutical Tablet Formulation (Nitrovasodilator Drugs)Large-scale manufacturers of anti-anginal pharmaceuticals routinely use isosorbide dinitrate mixtures in solid oral dosage forms. The finely adjusted ratio of active and excipient within our bulk material allows direct blending into tablet compaction stages. Controlled integration with lactose, starch, or phosphoric acid at ≥60% helps ensure stable drug release profiles and assists in meeting uniformity criteria during batch processing. Formulators optimize mixture selection based on required dissolution, compressibility, and regulatory monograph demands for EU and North American markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Sublingual Tablet ManufacturingProducers specializing in fast-acting cardiovascular delivery systems use this mixture for sublingual nitrovasodilator tablets. The excipient base (lactose or starch at high percentage) promotes rapid breakdown under the tongue, delivering active molecules quickly to the bloodstream. Pharmaceutical teams select mixture composition according to target disintegration times and regulatory guidance for critical therapies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Pharmaceutical Powder Sachets for Immediate-ReleaseOral powder sachet manufacturers incorporate this mixture for unit-dose cardiovascular therapies, enabling rapid and uniform dissolution in water or directly on the tongue. High-content excipient blends (lactose, starch, or phosphoric acid as applicable) facilitate flowability and prevent clumping during automated filling, supporting precision dosing. The material integrates reliably within powder blending equipment and high-speed fill lines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Bulk Active Ingredient Preparation for Injectable SolutionsAPI processors employ isosorbide dinitrate mixtures as a precursor in the preparation of bulk solutions for parenteral formulations. High-purity grades with excipient integration (typically phosphoric acid at ≥60%) support the stabilization of active components during wet granulation and allow accurate transfer to aqueous solution processing. Detailed batch records and in-process controls verify compliance throughout conversion to sterile dosage forms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Isosorbide Dinitrate Mixture [Lactose, Starch Or Phosphoric Acid ≥60%] prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
We manufacture chemicals for a living, and that job brings us in close contact with end users, regulatory teams, and product developers. Among our catalog, Isosorbide Dinitrate Mixture with carriers—specifically lactose, starch, or phosphoric acid at concentrations no less than 60%—represents a practical advance in the pharmaceutical and compounding sectors. Our plants mix every batch to meet batch consistency, dosing requirements, and efficient tablet formulation processes, so what you’re getting isn’t just a mixture tossed together, but the result of experience and refinement.
This mixture owes its existence to the demands of tabulating processes and modern compounding needs. Many pharmaceutical clients came to us over the years, frustrated by pure isosorbide dinitrate’s stability challenges and its tendency to clump or segregate in feeds. By integrating a carrier—lactose, starch, or phosphoric acid—the material handles better, flows more smoothly, and dosages calibrate more consistently in automated tablet presses. We maintain a carrier content that meets or exceeds 60%, striking a careful balance between active content and processing reliability. Direct compression grades remain the standard out of our factory, supporting high-throughput production lines.
Nobody in the chemicals business survives long by guessing. Batch homogeneity, particle size, and moisture control all become more than numbers on a spec sheet—they become points of pride. For our Isosorbide Dinitrate Mixture, those values come from trial, error, and dialogue with QC chemists downstream. Lactose-based mixtures suit applications demanding fast dissolution and compatibility with sugar-based excipients in oral tablets. Starch brings a slightly different profile, a touch more compressibility, and a preference among brands focused on gluten-free or allergen-conscious product lines. A phosphoric acid carrier adds flow benefits but also a buffering action, particularly sought after for formulations needing stable pH throughout shelf life.
We track median particle sizes to avoid both dusting and hard caking, monitoring moisture levels to keep every drum free-flowing from start to finish. Plant teams run compactors and sieves daily. Even after decades of production, we still rotate personnel through final quality inspections, chasing the kind of visual consistency and texture that might slip past laboratory instruments but not a seasoned factory worker’s hand.
Scaling up chemical production means learning what trips up machinery and people alike. Pure isosorbide dinitrate, without a carrier, resists even the best efforts to granulate or blend evenly. More than once, we’ve seen clients struggle—tablets come out uneven, assays bounce all over QC reports, or dust hazards mount up around automated lines. Using our compounded mixture, loaded up with carrier at purposeful concentrations, proves easier to pour, measure, and compress. It’s not about meeting theoretical requirements—it’s meeting the reality of hundreds of thousands of tablets an hour, eight hours a day, five days a week.
Long ago, our teams learned that adjusting carrier identity and load sometimes proves more valuable than tweaking the active ingredient itself. Lactose shows uniform dissolution and low reactivity, a trait well-documented in pharma compounding handbooks. Starch offers a cushioning effect during compression. Phosphoric acid, on the other hand, has helped several partners meet stringent shelf life stability standards, especially in climates with big ambient temperature swings. Some of these lessons appeared in journals, but just as many came from a shift supervisor’s notebook or a midline operator’s quick fix after a jammed machine.
Formulators and development chemists often share that they rely on our Isosorbide Dinitrate Mixture for more than its active content. Compounding centers across the globe use this product for solid dose manufacturing—mainly tablets and capsules—though it occasionally finds its way into pre-mix sachets. Large-scale generics manufacturers, hospital pharmacies, and contract development firms all look for reproducible release profiles, so they look for a blend that both mixes and compresses under stress.
That’s not because the product fits a checkbox, but because every successful run saves time and cost further down the line. Since this mixture proves compatible with most common pharmaceutical excipients, switching between lactose and starch carriers lets production lines adapt in response to ingredient shortages or regulatory changes regarding allergens and labeling. In some cases, the starch carrier receives preference in countries enforcing stricter labeling on lactose-containing drugs, or in markets with a high prevalence of lactose intolerance.
Quality control heads have told us they value the flow and compaction behavior of our mixtures, since excessive fines or wide variation in particle size have often led to off-spec batches in the past. By maintaining control over every phase—from raw material verification, carrier blending, active ingredient integration, and downstream sieving—we reduce the number of surprises during routine tableting operations.
Plenty of isosorbide dinitrate products flood the market, but not all mixtures act the same in the plant. Competitors sometimes push batches that clump under humid conditions, create dust hazards, or produce inconsistent tablet hardness. Taking manufacturing feedback seriously has allowed us to minimize surprises down the line. We keep carrier loads above the 60% mark, never cutting corners to keep costs low at the expense of flowing and compounding properties. Ultimately, we want our clients to spend less time cleaning feeders and more time counting finished tablets.
Every version from our facility ships with full batch records, real-world test results, and documentation for traceability, because regulatory bodies demand it and mistakes cost everyone down the pipeline. Many competitors outsource parts of the blending or only provide the active substance, pushing the burden of final formulation elsewhere. By controlling the mixing and packaging in-house, we account for every variable. If things go sideways, our process engineers can find root causes without delay, rather than passing blame up the supply chain.
Every plant engineer and compounding chemist knows the carrier doesn’t just “fill space”—it can make or break a process. A high-quality lactose or starch base prevents rapid settling or ingredient segregation, something our teams learned to appreciate after years of batch failures, rejected lots, and lost run time. The density and flow of a compound can mean the difference between an efficient high-speed press and a continuous fight with jamming.
Each carrier presents specific qualities. Lactose keeps batches sweet, easily digestible, and compatible with many existing excipients, which matters in countries with longstanding regulatory expectations. Starch, conversely, works well in vegetarian and gluten-free labeling efforts and sometimes provides superior mouthfeel in fast-dissolving or chewable tablets. Phosphoric acid as a carrier presents less sweetness but a finer edge—offering buffering effects that steady pH-sensitive molecules or formulations. Choosing this option, many partners have met extended shelf life demands from regulators or end markets.
Our own staff performed extended studies on how granule hardness and compression respond to minor changes in carrier ratio. That’s why we never push out a blend without beta testing it in tablet presses—the risk of crumbling or capping isn’t just theoretical; it disrupts schedules and costs money. Feedback from those shifts has shaped our production cycles, not just for the current lot, but future offerings intended for new markets.
Nobody asks for heavy documentation because they want a full bookshelf. Instead, they want certainty—proof that every kilogram handled, stored, and used lines up with what’s on the label. Every mixture out of our plants comes with process traceability logs, transport data, and up-to-date certificates drawn from batch-specific tests. Each mixing line operates with integrated monitoring, letting us spot trends and outliers before they trickle downstream. Years of audits and quality investigations taught us to document the obvious, not just the unusual, so questions about lot consistency, change of supplier for ingredients, or minor deviations in excipient granule shape can be answered straight from factory records.
We keep all original test data retrievable for years, so changes in industry guidance or questions from regulatory authorities find factual support, not hearsay. It also means end users spot trends—if a certain carrier or blend ratio supports a new finished form, the historic data shows up in our archives quickly. Direct communication lines between our QC, operations, and customer technical support staff allow rapid, informed responses about batch details wherever a shipment lands.
Rarely do innovations come only from the drawing board. Most of our improvements come from the frontlines—operators noting flow irregularities, supervisors tallying up downtime, or client pharmacists running finger tests on powder feel and dispersibility. We tweak carrier percentages, sieve settings, or final packaging based on those suggestions. Sticking to a rigid product sheet doesn’t get us far if people down the line are fighting jams or caked drums.
For example, after a set of customer complaints about caking during summer shipping, our team switched up moisture controls and ran extra batch tests using real transport conditions. Adjustments led directly to improved flow and opened new possibilities for shipping in harsher climates. Recently, more clients requested non-animal derived carrier options spurred by vegan labeling trends and new export regulations—we responded by dialing up our starch-based blend capacity, adjusting for the demands without sacrificing batch consistency.
Chemical manufacturing runs on a mix of skill and compliance. Health authorities in different regions expect their own standards: reproducibility, low variation, and documentation. We developed our workflow to intersect those checkpoints before product leaves our site. Each incoming lot receives barcoded tracking and full blend reports, so every customer and regulator sees the whole chain of custody, from carrier selection, lot blending, to final packaging runs. Mistakes on our end lead to batch rework, shipment holds, or worse—market recalls—which drives us to keep an unbroken audit trail.
Where global supply shifts have forced some to skimp or swap untested alternatives, we kept to strict sourcing checks for lactose, starch, and phosphoric acid. If one carrier faces tighter restrictions or labeling guidance shifts, we offer fast switchover options without disrupting client formulations. This flexibility opened new export markets, since regional differences in dietary regulations or consumer preferences can easily upend fixed product lines. Open, iterative feedback with plant partners and regulatory teams shapes continuous improvement, keeping the mixture ahead of coming compliance requirements, not caught playing catch-up.
Our employees, from the operators in the blending hall to the batch control managers, carry years of hands-on experience. Communication lines run both ways—clients update about changing needs, and we share production realities. Minor shifts in carrier sourcing or new performance trends set off internal reviews. Few factories have the luxury to ignore a jammed tablet press or batches lost to uneven blends, so feedback loops never close.
Experience means understanding not just the specifications but how every parameter shifts in the grind of production. Carrier choices tie in to running changes in equipment, process climate, or user preferences. As a result, every lot sent out represents hundreds of iterations, not a static, one-time formulation. We accept that no mixture will fit every application straight out of the drum; dialogue, troubleshooting, and minor reformulations fuel continued success for factories and pharmacists that depend on predictable throughput and compliance.
Since we run our own manufacturing floors, improvements take root quickly where they’re proven to work. Team leaders run post-mortem reviews after every lot, especially if a minor anomaly appears mid-run. Documentation teams collate these notes and any client feedback for monthly reviews, which directly trigger new trial batches or line upgrades. If an industry trend emerges—like new regulations on lactose or a rise in complex generic formulations—we pre-emptively test new carrier blends in tablet presses and stability chambers, keeping finished lots ready for rapid roll-out.
We invest as much in staff training as in equipment—teaching operators how to spot issues early, log unplanned variances, and communicate with QC or management teams without barriers. That approach means customer complaints rarely become recurring trends. By treating the mixture as a living, evolving product, not a commodity, we build in room to adapt and solve problems instead of blindly duplicating old solutions.
Newer projects also focus attention on sustainability, resource tracking, and minimizing waste streams. Carrier sourcing shifts according to both environmental concern and compliance with international standards. Our teams research bio-based starch alternatives and low-carbon supply chains for all raw components, responding to growing customer awareness regarding sustainable sourcing. These changes don’t just satisfy end users; they future-proof product pipelines, keep regulatory bodies informed, and ensure our operations stay viable no matter where or how the finished product ends up used.
Pharmaceutical development and chemical processing demand more than specification sheets. The Isosorbide Dinitrate Mixture we supply, built on a foundation of lactose, starch, or phosphoric acid at robust concentrations, reflects decades of iterative refinement, client engagement, and practical troubleshooting. Every drum that rolls out from our plant carries not just active ingredient, but the accumulated lessons of thousands of production hours, failures repurposed as improvements, and the shared expertise of a dedicated workforce.
That practical experience translates directly into predictable manufacturing outcomes—dosing accuracy, flow-through, safety standards, and ease of adjustment for evolving global standards. Whether a client prioritizes speed, stability, allergen compliance, or process flexibility, our Isosorbide Dinitrate Mixture offers options grounded in the realities of modern health and manufacturing demands. Performance, not promise, keeps customers returning batch after batch, for projects new and established.
From direct communication to continuous adaptation, every step along the supply chain reflects an ongoing commitment to get things right—not just once, but every time. We treat questions and errors as starting points for better product design, rather than faults to bury or ignore. That’s why our clients trust not just the chemical itself, but the team and philosophy behind every drum. Through this approach, innovation, safety, and operational smoothness become tightly linked, delivering results that outlast labels, product cycles, and regulatory reviews.